232 related articles for article (PubMed ID: 12584331)
21. Mutations in Both the Surface and Transmembrane Envelope Glycoproteins of the RAV-2 Subgroup B Avian Sarcoma and Leukosis Virus Are Required to Escape the Antiviral Effect of a Secreted Form of the Tvb
Yin X; Melder DC; Payne WS; Dodgson JB; Federspiel MJ
Viruses; 2019 May; 11(6):. PubMed ID: 31159208
[TBL] [Abstract][Full Text] [Related]
22. A fifteen-amino-acid TVB peptide serves as a minimal soluble receptor for subgroup B avian leukosis and sarcoma viruses.
Knauss DJ; Young JA
J Virol; 2002 Jun; 76(11):5404-10. PubMed ID: 11991969
[TBL] [Abstract][Full Text] [Related]
23. Receptor binding and low pH coactivate oncogenic retrovirus envelope-mediated fusion.
Côté M; Zheng YM; Liu SL
J Virol; 2009 Nov; 83(22):11447-55. PubMed ID: 19726505
[TBL] [Abstract][Full Text] [Related]
24. The central proline of an internal viral fusion peptide serves two important roles.
Delos SE; Gilbert JM; White JM
J Virol; 2000 Feb; 74(4):1686-93. PubMed ID: 10644338
[TBL] [Abstract][Full Text] [Related]
25. Cysteines flanking the internal fusion peptide are required for the avian sarcoma/leukosis virus glycoprotein to mediate the lipid mixing stage of fusion with high efficiency.
Delos SE; Brecher MB; Chen Z; Melder DC; Federspiel MJ; White JM
J Virol; 2008 Mar; 82(6):3131-4. PubMed ID: 18184714
[TBL] [Abstract][Full Text] [Related]
26. Analysis of the subgroup A avian sarcoma and leukosis virus receptor: the 40-residue, cysteine-rich, low-density lipoprotein receptor repeat motif of Tva is sufficient to mediate viral entry.
Rong L; Bates P
J Virol; 1995 Aug; 69(8):4847-53. PubMed ID: 7609052
[TBL] [Abstract][Full Text] [Related]
27. Effects of lipid rafts on dynamics of retroviral entry and trafficking: Quantitative analysis.
Lim KI; Narayan S; Young JA; Yin J
Biotechnol Bioeng; 2004 Jun; 86(6):650-60. PubMed ID: 15137076
[TBL] [Abstract][Full Text] [Related]
28. Two different molecular defects in the Tva receptor gene explain the resistance of two tvar lines of chickens to infection by subgroup A avian sarcoma and leukosis viruses.
Elleder D; Melder DC; Trejbalova K; Svoboda J; Federspiel MJ
J Virol; 2004 Dec; 78(24):13489-500. PubMed ID: 15564460
[TBL] [Abstract][Full Text] [Related]
29. Substitutions in the receptor-binding domain of the avian sarcoma and leukosis virus envelope uncouple receptor-triggered structural rearrangements in the surface and transmembrane subunits.
Damico R; Rong L; Bates P
J Virol; 1999 Apr; 73(4):3087-94. PubMed ID: 10074159
[TBL] [Abstract][Full Text] [Related]
30. Receptor-triggered membrane association of a model retroviral glycoprotein.
Damico RL; Crane J; Bates P
Proc Natl Acad Sci U S A; 1998 Mar; 95(5):2580-5. PubMed ID: 9482929
[TBL] [Abstract][Full Text] [Related]
31. Identification of two residues within the LDL-A module of Tva that dictate the altered receptor specificity of mutant subgroup A avian sarcoma and leukosis viruses.
Rai T; Caffrey M; Rong L
J Virol; 2005 Dec; 79(23):14962-6. PubMed ID: 16282495
[TBL] [Abstract][Full Text] [Related]
32. Structural characterization of a fusion glycoprotein from a retrovirus that undergoes a hybrid 2-step entry mechanism.
Aydin H; Smrke BM; Lee JE
FASEB J; 2013 Dec; 27(12):5059-71. PubMed ID: 24036886
[TBL] [Abstract][Full Text] [Related]
33. Visualization of the two-step fusion process of the retrovirus avian sarcoma/leukosis virus by cryo-electron tomography.
Cardone G; Brecher M; Fontana J; Winkler DC; Butan C; White JM; Steven AC
J Virol; 2012 Nov; 86(22):12129-37. PubMed ID: 22933285
[TBL] [Abstract][Full Text] [Related]
34. Critical role for the cysteines flanking the internal fusion peptide of avian sarcoma/leukosis virus envelope glycoprotein.
Delos SE; White JM
J Virol; 2000 Oct; 74(20):9738-41. PubMed ID: 11000247
[TBL] [Abstract][Full Text] [Related]
35. Receptor-induced conformational changes in the subgroup A avian leukosis and sarcoma virus envelope glycoprotein.
Gilbert JM; Hernandez LD; Balliet JW; Bates P; White JM
J Virol; 1995 Dec; 69(12):7410-5. PubMed ID: 7494245
[TBL] [Abstract][Full Text] [Related]
36. Soluble receptor-induced retroviral infection of receptor-deficient cells.
Damico R; Bates P
J Virol; 2000 Jul; 74(14):6469-75. PubMed ID: 10864659
[TBL] [Abstract][Full Text] [Related]
37. Reverse Engineering Provides Insights on the Evolution of Subgroups A to E Avian Sarcoma and Leukosis Virus Receptor Specificity.
Federspiel MJ
Viruses; 2019 May; 11(6):. PubMed ID: 31151254
[TBL] [Abstract][Full Text] [Related]
38. Cellular entry of retroviruses.
Lindemann D; Steffen I; Pöhlmann S
Adv Exp Med Biol; 2013; 790():128-49. PubMed ID: 23884589
[TBL] [Abstract][Full Text] [Related]
39. Stoichiometry of envelope glycoprotein trimers in the entry of human immunodeficiency virus type 1.
Yang X; Kurteva S; Ren X; Lee S; Sodroski J
J Virol; 2005 Oct; 79(19):12132-47. PubMed ID: 16160141
[TBL] [Abstract][Full Text] [Related]
40. Avian Sarcoma and Leukosis Virus Envelope Glycoproteins Evolve to Broaden Receptor Usage Under Pressure from Entry Competitors
Munguia A; Federspiel MJ
Viruses; 2019 Jun; 11(6):. PubMed ID: 31195660
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
